<p>DNA was isolated from pre-treatment and mid-treatment plasma samples and matched germline samples from patients undergoing chemoradiation therapy for stage IIB-IIIB non-small cell lung cancer. Sequencing libraries were hybrid captured using custom selector pools designed to target genes frequently mutated in non-small cell lung cancer prior to ultra-deep next generation sequencing.</p>

Integrating Circulating Tumor DNA Analysis and Radiomics for Dynamic Risk    Assessment in Localized Lung Cancer

Carcinoma, Non-Small-Cell Lung study with Targeted-Capture data on dbGaP (40 participants)